Addus HomeCare (NASDAQ:ADUS) Stock: Insider Monica Raines Sells 2,062 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Monica Raines sold 2,062 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $124.74, for a total value of $257,213.88. Following the completion of the sale, the executive vice president owned 13,577 shares of the company’s stock, valued at approximately $1,693,594.98. This trade represents a 13.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $125.49 on Thursday. The stock’s fifty day moving average price is $118.19 and its two-hundred day moving average price is $107.10. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $131.59. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64. The firm has a market cap of $2.34 billion, a PE ratio of 20.91, a price-to-earnings-growth ratio of 1.66 and a beta of 0.75.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.79 by $0.04. The firm had revenue of $387.74 million during the quarter, compared to analysts’ expectations of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.56 EPS. As a group, research analysts expect that Addus HomeCare Corporation will post 6.41 EPS for the current fiscal year.

Key Headlines Impacting Addus HomeCare

Here are a few of the latest headlines about ADUS:

• Neutral Sentiment: Addus plans to participate in the 2026 Stephens Annual Investment Conference. The announcement offers investor access but provides no new operating or financial guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
• Neutral Sentiment: A report claims short interest was zero shares, despite describing it as a large increase. The conflicting wording makes the short-interest update difficult to interpret.
• Negative Sentiment: Several executives sold shares on Nov. 6, and CEO R. Allison sold 98,958 shares on Nov. 9 for about $12.2 million, reducing his stake by 35.08%. Five executive vice presidents also sold a combined 32,697 shares. The volume of insider selling may weigh on investor sentiment, though sales alone do not establish a negative view of the company. CEO sale filing Article: EVP share sale

Wall Street Analyst Weigh In

ADUS has been the topic of a number of analyst reports. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. UBS Group boosted their target price on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Barclays boosted their target price on shares of Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research report on Wednesday, November 4th. TD Cowen upped their price target on shares of Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. Finally, Royal Bank Of Canada increased their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus price target of $134.70.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently modified their holdings of ADUS. NFJ Investment Group LLC bought a new stake in shares of Addus HomeCare during the 2nd quarter worth $29,000. Parallel Advisors LLC boosted its stake in Addus HomeCare by 66.3% in the first quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock valued at $38,000 after buying an additional 161 shares in the last quarter. Heritage Family Offices LLP bought a new position in Addus HomeCare in the third quarter valued at about $43,000. Hantz Financial Services Inc. grew its position in Addus HomeCare by 21.3% in the third quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock valued at $69,000 after acquiring an additional 109 shares during the last quarter. Finally, State of Wyoming bought a new position in Addus HomeCare in the second quarter valued at about $79,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.